Avanos Medical ( (AVNS) ) has shared an update.
Avanos Medical, Inc. announced the retirement of CEO Joseph Woody, who will continue as a consultant until April 2025, and appointed Michael C. Greiner as Interim CEO. Despite a slight dip in Q3 2024 sales, the company saw improved net income and adjusted EBITDA, driven by strong demand in its Digestive Health and Game Ready segments. As Avanos undergoes leadership transitions and evaluates candidates for a permanent CEO, it remains focused on achieving its financial goals and enhancing operational efficiency.
Find detailed analytics on AVNS stock on TipRanks’ Stock Analysis page.
